Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric Surgery

NCT04922333 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Bone Loss

Interventions

DRUG: Risedronate
DRUG: Placebo

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]